{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:05:52Z","timestamp":1791947152628,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Mental Health, Grant\/Award Numbers","award":["F31MH119699"],"award-info":[{"award-number":["F31MH119699"]}]},{"name":"National Institute of Mental Health, Grant\/Award Numbers","award":["R01NS112171"],"award-info":[{"award-number":["R01NS112171"]}]},{"name":"National Institute of Mental Health, Grant\/Award Numbers","award":["R01MH124671"],"award-info":[{"award-number":["R01MH124671"]}]},{"name":"International Rett Syndrome Foundation Award","award":["3903"],"award-info":[{"award-number":["3903"]}]},{"name":"International Rett Syndrome Foundation Award","award":["3903"],"award-info":[{"award-number":["3903"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metabotropic glutamate receptor 7 (mGlu<jats:sub>7<\/jats:sub>) is a G protein-coupled receptor (GPCR) involved in neurotransmitter release throughout the central nervous system (CNS). Low levels of the receptor are correlated with intellectual disability, autism, repetitive behaviors, and seizures in patients with neurodevelopmental disorders (NDDs), including the disease Rett syndrome. These findings suggest that increasing mGlu<jats:sub>7<\/jats:sub> activity may be of therapeutic benefit. In the current manuscript, we report the characterization of a novel transgenic mouse that overexpresses the human <jats:italic>GRM7B<\/jats:italic> splice variant at approximately fivefold higher levels compared to wild-type (WT) littermates. These animals exhibit a reciprocal decrease in expression of the mouse mGlu<jats:sub>7A<\/jats:sub> splice isoform, suggesting feedback regulation of receptor expression. Previous studies from our lab and others have shown that mGlu<jats:sub>7<\/jats:sub> activation is permissive for long-term potentiation induction in the hippocampus and amygdala. Here, we identified subtle differences in agonist-modulated hippocampal field recordings in mice overexpressing mGlu<jats:sub>7B<\/jats:sub>, but no changes in theta burst-induced long-term potentiation. Our lab previously characterized behavioral phenotypes in <jats:italic>Grm7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> animals that were observed in other animal models of NDDs. Surprisingly, we find here that mGlu<jats:sub>7B<\/jats:sub>-overexpressing mice exhibit similar phenotypes to previously reported studies in <jats:italic>Grm7<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> animals in repetitive behavior and cognition assays. Overall, these findings suggest that precise control of mGlu<jats:sub>7<\/jats:sub> may be required to avoid abnormal phenotypes.<\/jats:p>","DOI":"10.1007\/s12035-025-05183-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T11:03:04Z","timestamp":1752145384000},"page":"14015-14031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overexpression of mGlu7B in Mice: Implications for Neurodevelopmental Disorders"],"prefix":"10.1007","volume":"62","author":[{"given":"Geanne A.","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Bavadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl Anne D.","family":"Vermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco G.","family":"Gogliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"5183_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295\u2013322","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5183_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/cercor\/12.9.961","volume":"12","author":"Y Dalezios","year":"2002","unstructured":"Dalezios Y, Lujan R, Shigemoto R, Roberts JD, Somogyi P (2002) Enrichment of mGluR7a in the presynaptic active zones of GABAergic and non-GABAergic terminals on interneurons in the rat somatosensory cortex. Cereb Cortex 12:961\u2013974","journal-title":"Cereb Cortex"},{"key":"5183_CR3","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1046\/j.1460-9568.2003.02697.x","volume":"17","author":"P Somogyi","year":"2003","unstructured":"Somogyi P, Dalezios Y, Lujan R, Roberts JD, Watanabe M, Shigemoto R (2003) High level of mGluR7 in the presynaptic active zones of select populations of GABAergic terminals innervating interneurons in the rat hippocampus. Eur J Neurosci 17:2503\u20132520","journal-title":"Eur J Neurosci"},{"key":"5183_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1046\/j.1471-4159.1998.71020636.x","volume":"71","author":"SR Bradley","year":"1998","unstructured":"Bradley SR, Rees HD, Yi H, Levey AI, Conn PJ (1998) Distribution and developmental regulation of metabotropic glutamate receptor 7a in rat brain. J Neurochem 71:636\u2013645","journal-title":"J Neurochem"},{"key":"5183_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1176\/appi.ajp.2011.11060835","volume":"168","author":"SP Hamilton","year":"2011","unstructured":"Hamilton SP (2011) A new lead from genetic studies in depressed siblings: assessing studies of chromosome 3. Am J Psychiatry 168:783\u2013789","journal-title":"Am J Psychiatry"},{"key":"5183_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1176\/appi.ajp.2011.10091342","volume":"168","author":"G Breen","year":"2011","unstructured":"Breen G, Webb BT, Butler AW, van den Oord EJ, Tozzi F, Craddock N, Gill M, Korszun A et al (2011) A genome-wide significant linkage for severe depression on chromosome 3: the Depression Network Study. Am J Psychiatry 168:840\u2013847","journal-title":"Am J Psychiatry"},{"key":"5183_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1017\/S1461145709990356","volume":"12","author":"C Ganda","year":"2009","unstructured":"Ganda C, Schwab SG, Amir N, Heriani H, Irmansyah I, Kusumawardhani A, Nasrun M, Widyawati I et al (2009) A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population. Int J Neuropsychopharmacol 12:1283\u20131289","journal-title":"Int J Neuropsychopharmacol"},{"key":"5183_CR8","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/ajmg.b.30865","volume":"147B","author":"E Mick","year":"2008","unstructured":"Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV (2008) Genome-wide association study of response to methylphenidate in 187 children with attention-deficit\/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1412\u20131418","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5183_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lfs.2012.11.010","volume":"92","author":"Y Yang","year":"2013","unstructured":"Yang Y, Pan C (2013) Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. Life Sci 92:149\u2013153","journal-title":"Life Sci"},{"key":"5183_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/cap.2013.0079","volume":"24","author":"S Park","year":"2014","unstructured":"Park S, Kim BN, Cho SC, Kim JW, Kim JI, Shin MS, Yoo HJ, Han DH et al (2014) The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 24:223\u2013227","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"5183_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ng.1013","volume":"44","author":"J Elia","year":"2012","unstructured":"Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM, Zhang H et al (2012) Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 44:78\u201384","journal-title":"Nat Genet"},{"key":"5183_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2008.01.027","volume":"101","author":"T Ohtsuki","year":"2008","unstructured":"Ohtsuki T, Koga M, Ishiguro H, Horiuchi Y, Arai M, Niizato K, Itokawa M, Inada T et al (2008) A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia. Schizophr Res 101:9\u201316","journal-title":"Schizophr Res"},{"key":"5183_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.psychres.2007.12.002","volume":"167","author":"H Shibata","year":"2009","unstructured":"Shibata H, Tani A, Chikuhara T, Kikuta R, Sakai M, Ninomiya H, Tashiro N, Iwata N et al (2009) Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia. Psychiatry Res 167:88\u201396","journal-title":"Psychiatry Res"},{"key":"5183_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jpsychires.2010.03.007","volume":"44","author":"E Saus","year":"2010","unstructured":"Saus E, Brunet A, Armengol L, Alonso P, Crespo JM, Fernandez-Aranda F, Guitart M, Martin-Santos R et al (2010) Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J Psychiatr Res 44:971\u2013978","journal-title":"J Psychiatr Res"},{"key":"5183_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.schres.2014.12.031","volume":"162","author":"A Jajodia","year":"2015","unstructured":"Jajodia A, Kaur H, Kumari K, Gupta M, Baghel R, Srivastava A, Sood M, Chadda RK et al (2015) Evidence for schizophrenia susceptibility alleles in the Indian population: an association of neurodevelopmental genes in case-control and familial samples. Schizophr Res 162:112\u2013117","journal-title":"Schizophr Res"},{"key":"5183_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ajmg.b.32239","volume":"165B","author":"R Kandaswamy","year":"2014","unstructured":"Kandaswamy R, McQuillin A, Curtis D, Gurling H (2014) Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 165B:365\u2013372","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5183_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/YPG.0b013e3283457a31","volume":"21","author":"N Alliey-Rodriguez","year":"2011","unstructured":"Alliey-Rodriguez N, Zhang D, Badner JA, Lahey BB, Zhang X, Dinwiddie S, Romanos B, Plenys N et al (2011) Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet 21:190\u2013194","journal-title":"Psychiatr Genet"},{"key":"5183_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/JAD-148009","volume":"45","author":"K Nho","year":"2015","unstructured":"Nho K, Ramanan VK, Horgusluoglu E, Kim S, Inlow MH, Risacher SL, McDonald BC, Farlow MR et al (2015) Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults. J Alzheimers Dis 45:1197\u20131206","journal-title":"J Alzheimers Dis"},{"key":"5183_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2015.02.025","volume":"77","author":"S Haenisch","year":"2015","unstructured":"Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK et al (2015) SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiol Dis 77:127\u2013140","journal-title":"Neurobiol Dis"},{"key":"5183_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104483","volume":"129","author":"R Noroozi","year":"2019","unstructured":"Noroozi R, Taheri M, Omrani MD, Ghafouri-Fard S (2019) Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder. Neurochem Int 129:104483","journal-title":"Neurochem Int"},{"key":"5183_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12920-016-0208-3","volume":"9","author":"WL Charng","year":"2016","unstructured":"Charng WL, Karaca E, Coban Akdemir Z, Gambin T, Atik MM, Gu S, Posey JE, Jhangiani SN et al (2016) Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate. BMC Med Genomics 9:42","journal-title":"BMC Med Genomics"},{"key":"5183_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamapsychiatry.2016.3798","volume":"74","author":"MS Reuter","year":"2017","unstructured":"Reuter MS, Tawamie H, Buchert R, Hosny Gebril O, Froukh T, Thiel C, Uebe S, Ekici AB et al (2017) Diagnostic yield and novel candidate genes by exome sequencing in 152 consanguineous families with neurodevelopmental disorders. JAMA Psychiat 74:293\u2013299","journal-title":"JAMA Psychiat"},{"key":"5183_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature10945","volume":"485","author":"SJ Sanders","year":"2012","unstructured":"Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG et al (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237\u2013241","journal-title":"Nature"},{"key":"5183_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ajmg.b.32306","volume":"168B","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhang Y, Zhao D, Dong R, Yang X, Tammimies K, Uddin M, Scherer SW et al (2015) Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 168B:258\u2013264","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5183_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/acn3.51003","volume":"7","author":"D Marafi","year":"2020","unstructured":"Marafi D, Mitani T, Isikay S, Hertecant J, Almannai M, Manickam K, Abou Jamra R, El-Hattab AW et al (2020) Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy. Ann Clin Transl Neurol 7:610\u2013627","journal-title":"Ann Clin Transl Neurol"},{"key":"5183_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143324","volume":"6","author":"NM Fisher","year":"2021","unstructured":"Fisher NM, AlHashim A, Buch AB, Badivuku H, Samman MM, Weiss KM, Cestero GI, Does MD et al (2021) A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes. JCI Insight 6:e143324. https:\/\/doi.org\/10.1172\/jci.insight.143324","journal-title":"JCI Insight"},{"key":"5183_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2023.173546","volume":"225","author":"GA Freitas","year":"2023","unstructured":"Freitas GA, Niswender CM (2023) GRM7 gene mutations and consequences for neurodevelopment. Pharmacol Biochem Behav 225:173546","journal-title":"Pharmacol Biochem Behav"},{"key":"5183_CR28","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1523\/JNEUROSCI.2108-20.2021","volume":"41","author":"JM Song","year":"2021","unstructured":"Song JM, Kang M, Park DH, Park S, Lee S, Suh YH (2021) Pathogenic GRM7 mutations associated with neurodevelopmental disorders impair axon outgrowth and presynaptic terminal development. J Neurosci 41:2344\u20132359","journal-title":"J Neurosci"},{"key":"5183_CR29","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1523\/JNEUROSCI.21-22-08734.2001","volume":"21","author":"G Sansig","year":"2001","unstructured":"Sansig G, Bushell TJ, Clarke VR, Rozov A, Burnashev N, Portet C, Gasparini F, Schmutz M et al (2001) Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J Neurosci 21:8734\u20138745","journal-title":"J Neurosci"},{"key":"5183_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1100\/tsw.2002.146","volume":"2","author":"TJ Bushell","year":"2002","unstructured":"Bushell TJ, Sansig G, Collett VJ, van der Putten H, Collingridge GL (2002) Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. ScientificWorldJournal 2:730\u2013737","journal-title":"ScientificWorldJournal"},{"key":"5183_CR31","doi-asserted-by":"publisher","first-page":"e1265","DOI":"10.1111\/gbb.12654","volume":"19","author":"NM Fisher","year":"2020","unstructured":"Fisher NM, Gould RW, Gogliotti RG, McDonald AJ, Badivuku H, Chennareddy S, Buch AB, Moore AM et al (2020) Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders. Genes Brain Behav 19:e1265. https:\/\/doi.org\/10.1111\/gbb.12654","journal-title":"Genes Brain Behav"},{"key":"5183_CR32","doi-asserted-by":"publisher","unstructured":"Fisher NM, Seto M, Lindsley CW, Niswender CM (2018) Metabotropic glutamate receptor 7: a new therapeutic target in neurodevelopmental disorders. Front Mol Neurosci 11.https:\/\/doi.org\/10.3389\/fnmol.2018.00387","DOI":"10.3389\/fnmol.2018.00387"},{"key":"5183_CR33","doi-asserted-by":"publisher","unstructured":"Tassin V, Girard B, Chotte A, Fontanaud P, Rigault D, Kalinichev M, Perroy J, Acher F, et al (2016) Phasic and tonic mGlu7 receptor activity modulates the thalamocortical network. Front Neural Circuits 10:31. https:\/\/doi.org\/10.3389\/fncir.2016.00031","DOI":"10.3389\/fncir.2016.00031"},{"key":"5183_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2019.04.016","volume":"129","author":"B Girard","year":"2019","unstructured":"Girard B, Tuduri P, Moreno MP, Sakkaki S, Barboux C, Bouschet T, Varrault A, Vitre J et al (2019) The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures. Neurobiol Dis 129:13\u201328","journal-title":"Neurobiol Dis"},{"key":"5183_CR35","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","volume":"17","author":"JF Cryan","year":"2003","unstructured":"Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H (2003) Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 17:2409\u20132417","journal-title":"Eur J Neurosci"},{"key":"5183_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbr.2004.03.015","volume":"154","author":"C Holscher","year":"2004","unstructured":"Holscher C, Schmid S, Pilz PK, Sansig G, van der Putten H, Plappert CF (2004) Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memory. Behav Brain Res 154:473\u2013481","journal-title":"Behav Brain Res"},{"key":"5183_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1101\/lm.98305","volume":"12","author":"C Holscher","year":"2005","unstructured":"Holscher C, Schmid S, Pilz PK, Sansig G, van der Putten H, Plappert CF (2005) Lack of the metabotropic glutamate receptor subtype 7 selectively modulates theta rhythm and working memory. Learn Mem 12:450\u2013455","journal-title":"Learn Mem"},{"key":"5183_CR38","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1523\/JNEUROSCI.19-03-00955.1999","volume":"19","author":"M Masugi","year":"1999","unstructured":"Masugi M, Yokoi M, Shigemoto R, Muguruma K, Watanabe Y, Sansig G, van der Putten H, Nakanishi S (1999) Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J Neurosci 19:955\u2013963","journal-title":"J Neurosci"},{"key":"5183_CR39","doi-asserted-by":"publisher","first-page":"10975","DOI":"10.1074\/jbc.M113.542654","volume":"289","author":"CE Gee","year":"2014","unstructured":"Gee CE, Peterlik D, Neuhauser C, Bouhelal R, Kaupmann K, Laue G, Uschold-Schmidt N, Feuerbach D et al (2014) Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior. J Biol Chem 289:10975\u201310987","journal-title":"J Biol Chem"},{"key":"5183_CR40","doi-asserted-by":"publisher","first-page":"7600","DOI":"10.1523\/JNEUROSCI.4543-14.2015","volume":"35","author":"R Klar","year":"2015","unstructured":"Klar R, Walker AG, Ghose D, Grueter BA, Engers DW, Hopkins CR, Lindsley CW, Xiang Z et al (2015) Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SC-CA1 synapses in the hippocampus. J Neurosci 35:7600\u20137615","journal-title":"J Neurosci"},{"key":"5183_CR41","doi-asserted-by":"publisher","first-page":"eaai7459","DOI":"10.1126\/scitranslmed.aai7459","volume":"9","author":"RG Gogliotti","year":"2017","unstructured":"Gogliotti RG, Senter RK, Fisher NM, Adams J, Zamorano R, Walker AG, Blobaum AL, Engers DW et al (2017) mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome. Sci Transl Med 9:eaai7459. https:\/\/doi.org\/10.1126\/scitranslmed.aai7459","journal-title":"Sci Transl Med"},{"key":"5183_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185\u2013188","journal-title":"Nat Genet"},{"key":"5183_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","volume":"19","author":"JPK Ip","year":"2018","unstructured":"Ip JPK, Mellios N, Sur M (2018) Rett syndrome: insights into genetic, molecular and circuit mechanisms. Nat Rev Neurosci 19:368\u2013382","journal-title":"Nat Rev Neurosci"},{"key":"5183_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pedneo.2011.08.002","volume":"52","author":"SM Weng","year":"2011","unstructured":"Weng SM, Bailey ME, Cobb SR (2011) Rett syndrome: from bed to bench. Pediatr Neonatol 52:309\u2013316","journal-title":"Pediatr Neonatol"},{"key":"5183_CR45","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s40263-024-01106-y","volume":"38","author":"AK Percy","year":"2024","unstructured":"Percy AK, Ananth A, Neul JL (2024) Rett syndrome: the emerging landscape of treatment strategies. CNS Drugs 38:851\u2013867","journal-title":"CNS Drugs"},{"key":"5183_CR46","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","volume":"26","author":"F Bedogni","year":"2016","unstructured":"Bedogni F, Cobolli Gigli C, Pozzi D, Rossi RL, Scaramuzza L, Rossetti G, Pagani M, Kilstrup-Nielsen C et al (2016) Defects during Mecp2 null embryonic cortex development precede the onset of overt neurological symptoms. Cereb Cortex 26:2517\u20132529","journal-title":"Cereb Cortex"},{"key":"5183_CR47","doi-asserted-by":"publisher","first-page":"689611","DOI":"10.3389\/fncel.2021.689611","volume":"15","author":"X Wang","year":"2021","unstructured":"Wang X, Gao C, Zhang Y, Hu S, Qiao Y, Zhao Z, Gou L, Song J et al (2021) Overexpression of mGluR7 in the prefrontal cortex attenuates autistic behaviors in mice. Front Cell Neurosci 15:689611","journal-title":"Front Cell Neurosci"},{"key":"5183_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/1570159X13666150716165323","volume":"14","author":"E Palazzo","year":"2016","unstructured":"Palazzo E, Marabese I, de Novellis V, Rossi F, Maione S (2016) Metabotropic glutamate receptor 7: from synaptic function to therapeutic implications. Curr Neuropharmacol 14:504\u2013513","journal-title":"Curr Neuropharmacol"},{"key":"5183_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ejhg.2012.78","volume":"20","author":"J Vengoechea","year":"2012","unstructured":"Vengoechea J, Parikh AS, Zhang S, Tassone F (2012) De novo microduplication of the FMR1 gene in a patient with developmental delay, epilepsy and hyperactivity. European journal of human genetics\u202f: EJHG 20:1197\u20131200","journal-title":"European journal of human genetics : EJHG"},{"key":"5183_CR50","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ejhg.2012.175","volume":"21","author":"L Boccuto","year":"2013","unstructured":"Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, Collins JS et al (2013) Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet 21:310\u2013316","journal-title":"Eur J Hum Genet"},{"key":"5183_CR51","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ejhg.2014.217","volume":"23","author":"P Szafranski","year":"2015","unstructured":"Szafranski P, Golla S, Jin W, Fang P, Hixson P, Matalon R, Kinney D, Bock HG et al (2015) Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications. Eur J Hum Genet 23:915\u2013921","journal-title":"Eur J Hum Genet"},{"key":"5183_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nature12630","volume":"503","author":"K Han","year":"2013","unstructured":"Han K, Holder JL Jr, Schaaf CP, Lu H, Chen H, Kang H, Tang J, Wu Z et al (2013) SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503:72\u201377","journal-title":"Nature"},{"key":"5183_CR53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","volume":"152A","author":"MB Ramocki","year":"2010","unstructured":"Ramocki MB, Tavyev YJ, Peters SU (2010) The MECP2 duplication syndrome. Am J Med Genet A 152A:1079\u20131088","journal-title":"Am J Med Genet A"},{"issue":"8","key":"5183_CR54","first-page":"1111","volume":"9","author":"D Ta","year":"2022","unstructured":"Ta D, Downs J, Baynam G, Wilson A, Richmond P, Schmidt A, Decker A, Leonard H (2022) Development of an International Database for a Rare Genetic Disorder: The MECP2 Duplication Database (MDBase). Children (Basel) 9(8):1111","journal-title":"Children (Basel)"},{"key":"5183_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-022-02278-w","volume":"17","author":"D Ta","year":"2022","unstructured":"Ta D, Downs J, Baynam G, Wilson A, Richmond P, Leonard H (2022) A brief history of MECP2 duplication syndrome: 20-years of clinical understanding. Orphanet J Rare Dis 17:131","journal-title":"Orphanet J Rare Dis"},{"key":"5183_CR56","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1046\/j.1460-9568.1998.00371.x","volume":"10","author":"C Corti","year":"1998","unstructured":"Corti C, Restituito S, Rimland JM, Brabet I, Corsi M, Pin JP, Ferraguti F (1998) Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. Eur J Neurosci 10:3629\u20133641","journal-title":"Eur J Neurosci"},{"key":"5183_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"issue":"6","key":"5183_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.biopsych.2021.02.970","volume":"90","author":"S Dogra","year":"2021","unstructured":"Dogra S, Stansley BJ, Xiang Z, Qian W, Gogliotti RG, Nicoletti F, Lindsley CW, Niswender CM et al (2021) Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus. Biol Psychiatry 90(6):385\u2013398","journal-title":"Biol Psychiatry"},{"key":"5183_CR59","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.jbc.2022.102458","volume":"298","author":"X Lin","year":"2022","unstructured":"Lin X, Fisher NM, Dogra S, Senter RK, Reed CW, Kalbfleisch JJ, Lindsley CW, Asher WB et al (2022) Differential activity of mGlu(7) allosteric modulators provides evidence for mGlu(7\/8) heterodimers at hippocampal Schaffer collateral-CA1 synapses. J Biol Chem 298:102458","journal-title":"J Biol Chem"},{"issue":"10","key":"5183_CR60","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/hmg\/ddw074","volume":"25","author":"RG Gogliotti","year":"2016","unstructured":"Gogliotti RG, Senter RK, Rook JM, Ghoshal A, Zamorano R, Malosh C, Stauffer SR, Bridges TM et al (2016) mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome. Hum Mol Genet 25(10):1990\u20132004","journal-title":"Hum Mol Genet"},{"key":"5183_CR61","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/npp.2014.2","volume":"39","author":"NE Byun","year":"2014","unstructured":"Byun NE, Grannan M, Bubser M, Barry RL, Thompson A, Rosanelli J, Gowrishankar R, Kelm ND et al (2014) Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Neuropsychopharmacology 39:1578\u20131593","journal-title":"Neuropsychopharmacology"},{"key":"5183_CR62","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1021\/cn500128b","volume":"5","author":"M Bubser","year":"2014","unstructured":"Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM et al (2014) Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents. ACS Chem Neurosci 5:920\u2013942","journal-title":"ACS Chem Neurosci"},{"key":"5183_CR63","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1021\/jm400650w","volume":"56","author":"JM Bartolome-Nebreda","year":"2013","unstructured":"Bartolome-Nebreda JM, Conde-Ceide S, Delgado F, Iturrino L, Pastor J, Pena MA, Trabanco AA, Tresadern G et al (2013) Dihydrothiazolopyridone derivatives as a novel family of positive allosteric modulators of the metabotropic glutamate 5 (mGlu5) receptor. J Med Chem 56:7243\u20137259","journal-title":"J Med Chem"},{"key":"5183_CR64","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/jpet.113.206623","volume":"347","author":"KJ Gregory","year":"2013","unstructured":"Gregory KJ, Herman EJ, Ramsey AJ, Hammond AS, Byun NE, Stauffer SR, Manka JT, Jadhav S et al (2013) N-Aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement. J Pharmacol Exp Ther 347:438\u2013457","journal-title":"J Pharmacol Exp Ther"},{"key":"5183_CR65","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1124\/jpet.108.140350","volume":"327","author":"AE Brady","year":"2008","unstructured":"Brady AE, Jones CK, Bridges TM, Kennedy JP, Thompson AD, Heiman JU, Breininger ML, Gentry PR et al (2008) Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats. J Pharmacol Exp Ther 327:941\u2013953","journal-title":"J Pharmacol Exp Ther"},{"key":"5183_CR66","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/jpet.105.091074","volume":"315","author":"R Galici","year":"2005","unstructured":"Galici R, Echemendia NG, Rodriguez AL, Conn PJ (2005) A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2\/3 receptor agonist in mouse models predictive of antipsychotic activity. J Pharmacol Exp Ther 315:1181\u20131187","journal-title":"J Pharmacol Exp Ther"},{"key":"5183_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/jpet.104.079244","volume":"313","author":"GG Kinney","year":"2005","unstructured":"Kinney GG, O\u2019Brien JA, Lemaire W, Burno M, Bickel DJ, Clements MK, Chen TB, Wisnoski DD et al (2005) A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther 313:199\u2013206","journal-title":"J Pharmacol Exp Ther"},{"key":"5183_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/jpet.103.048702","volume":"306","author":"GG Kinney","year":"2003","unstructured":"Kinney GG, Burno M, Campbell UC, Hernandez LM, Rodriguez D, Bristow LJ, Conn PJ (2003) Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 306:116\u2013123","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"5183_CR69","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1038\/s41380-018-0206-2","volume":"25","author":"SE Yohn","year":"2020","unstructured":"Yohn SE, Foster DJ, Covey DP, Moehle MS, Galbraith J, Garcia-Barrantes PM, Cho HP, Bubser M, Blobaum AL, Joffe ME, Cheer JF, Jones CK, Lindsley CW, Conn PJ (2020) Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators. Mol Psychiatry 25(11):2786\u20132799","journal-title":"Mol Psychiatry"},{"key":"5183_CR70","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/cn500153z","volume":"5","author":"N Jalan-Sakrikar","year":"2014","unstructured":"Jalan-Sakrikar N, Field JR, Klar R, Mattmann ME, Gregory KJ, Zamorano R, Engers DW, Bollinger SR et al (2014) Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7. ACS Chem Neurosci 5:1221\u20131237","journal-title":"ACS Chem Neurosci"},{"key":"5183_CR71","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neuropharm.2007.12.009","volume":"54","author":"JE Ayala","year":"2008","unstructured":"Ayala JE, Niswender CM, Luo Q, Banko JL, Conn PJ (2008) Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated. Neuropharmacology 54:804\u2013814","journal-title":"Neuropharmacology"},{"key":"5183_CR72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1124\/jpet.117.246991","volume":"365","author":"RG Gogliotti","year":"2018","unstructured":"Gogliotti RG, Fisher NM, Stansley BJ, Jones CK, Lindsley CW, Conn PJ, Niswender CM (2018) Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target. J Pharmacol Exp Ther 365:291\u2013300","journal-title":"J Pharmacol Exp Ther"},{"key":"5183_CR73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","volume":"5","author":"SE Sinnett","year":"2017","unstructured":"Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR et al (2017) Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery. Mol Ther Methods Clin Dev 5:106\u2013115","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5183_CR74","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143\u20131147","journal-title":"Science"},{"key":"5183_CR75","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322\u2013326","journal-title":"Nat Genet"},{"key":"5183_CR76","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","volume":"23","author":"F Schwenk","year":"1995","unstructured":"Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080\u20135081","journal-title":"Nucleic Acids Res"},{"key":"5183_CR77","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1113\/jphysiol.1991.sp018901","volume":"444","author":"A Baskys","year":"1991","unstructured":"Baskys A, Malenka RC (1991) Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus. J Physiol 444:687\u2013701","journal-title":"J Physiol"},{"key":"5183_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12868-12015-10154-12866","volume":"16","author":"PJ Kammermeier","year":"2015","unstructured":"Kammermeier PJ (2015) Constitutive activity of metabotropic glutamate receptor 7. BMC Neurosci 16:17. https:\/\/doi.org\/10.1186\/s12868-12015-10154-12866","journal-title":"BMC Neurosci"},{"key":"5183_CR79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/molpharm.123.000678","volume":"104","author":"X Lei","year":"2023","unstructured":"Lei X, Hofmann CS, Rodriguez AL, Niswender CM (2023) Differential activity of orthosteric agonists and allosteric modulators at metabotropic glutamate receptor 7. Mol Pharmacol 104:17\u201327","journal-title":"Mol Pharmacol"},{"key":"5183_CR80","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1124\/mol.107.041053","volume":"73","author":"CM Niswender","year":"2008","unstructured":"Niswender CM, Johnson KA, Luo Q, Ayala JE, Kim C, Conn PJ, Weaver CD (2008) A novel assay of Gi\/o-linked G protein coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. Mol Pharmacol 73:1213\u20131224","journal-title":"Mol Pharmacol"},{"key":"5183_CR81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2006.07.020","volume":"52","author":"KA Pelkey","year":"2007","unstructured":"Pelkey KA, Yuan X, Lavezzari G, Roche KW, McBain CJ (2007) mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52:108\u2013117","journal-title":"Neuropharmacology"},{"key":"5183_CR82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuron.2005.02.011","volume":"46","author":"KA Pelkey","year":"2005","unstructured":"Pelkey KA, Lavezzari G, Racca C, Roche KW, McBain CJ (2005) mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron 46:89\u2013102","journal-title":"Neuron"},{"key":"5183_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1096\/fj.10-163147","volume":"25","author":"E Doumazane","year":"2011","unstructured":"Doumazane E, Scholler P, Zwier JM, Trinquet E, Rondard P, Pin JP (2011) A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J 25:66\u201377","journal-title":"FASEB J"},{"key":"5183_CR84","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang Z, Moreno-Delgado D, Dalton JA, Rovira X, Trapero A, Goudet C, Llebaria A, et al (2017) Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer. Elife 6. https:\/\/doi.org\/10.7554\/eLife.26985","DOI":"10.7554\/eLife.26985"},{"key":"5183_CR85","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.1038\/s41467-024-52822-4","volume":"15","author":"X Lin","year":"2024","unstructured":"Lin X, Provasi D, Niswender CM, Asher WB, Javitch JA (2024) Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer. Nat Commun 15:8552","journal-title":"Nat Commun"},{"key":"5183_CR86","doi-asserted-by":"crossref","unstructured":"Xiang Z, Lv X, Lin X, O\u2019Brien DE, Altman MK, Lindsley CW, Javitch JA, Niswender CM, et al (2021) Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu2\/mGlu4 receptor heterodimers. Sci Signal 14:eabd2319","DOI":"10.1126\/scisignal.abd2319"},{"key":"5183_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","volume":"8","author":"B Hagberg","year":"2002","unstructured":"Hagberg B (2002) Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:61\u201365","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"5183_CR88","doi-asserted-by":"crossref","unstructured":"Lopes AG, Loganathan SK, Caliaperumal J (2024) Rett syndrome and the role of MECP2: signaling to clinical trials. Brain Sci 14(2:12):120","DOI":"10.3390\/brainsci14020120"},{"key":"5183_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10354-016-0491-9","volume":"166","author":"AK Percy","year":"2016","unstructured":"Percy AK (2016) Progress in Rett syndrome: from discovery to clinical trials. Wien Med Wochenschr 166:325\u2013332","journal-title":"Wien Med Wochenschr"},{"key":"5183_CR90","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/aur.1262","volume":"6","author":"SU Peters","year":"2013","unstructured":"Peters SU, Hundley RJ, Wilson AK, Warren Z, Vehorn A, Carvalho CM, Lupski JR, Ramocki MB (2013) The behavioral phenotype in MECP2 duplication syndrome: a comparison with idiopathic autism. Autism research\u202f: official journal of the International Society for Autism Research 6:42\u201350","journal-title":"Autism research : official journal of the International Society for Autism Research"},{"key":"5183_CR91","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neuron.2016.07.018","volume":"91","author":"H Lu","year":"2016","unstructured":"Lu H, Ash RT, He L, Kee SE, Wang W, Yu D, Hao S, Meng X et al (2016) Loss and gain of MeCP2 cause similar hippocampal circuit dysfunction that is rescued by deep brain stimulation in a Rett syndrome mouse model. Neuron 91:739\u2013747","journal-title":"Neuron"},{"key":"5183_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091148","volume":"9","author":"EC Ho","year":"2014","unstructured":"Ho EC, Eubanks JH, Zhang L, Skinner FK (2014) Network models predict that reduced excitatory fluctuations can give rise to hippocampal network hyper-excitability in MeCP2-null mice. PLoS ONE 9:e91148","journal-title":"PLoS ONE"},{"key":"5183_CR93","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1038\/s41467-41019-13407-41468","volume":"10","author":"CH Habrian","year":"2019","unstructured":"Habrian CH, Levitz J, Vyklicky V, Fu Z, Hoagland A, McCort-Tranchepain I, Acher F, Isacoff EY (2019) Conformational pathway provides unique sensitivity to a synaptic mGluR. Nat Commun 10:5572. https:\/\/doi.org\/10.1038\/s41467-41019-13407-41468","journal-title":"Nat Commun"},{"key":"5183_CR94","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1046\/j.1471-4159.2002.00922.x","volume":"81","author":"R Enz","year":"2002","unstructured":"Enz R (2002) The metabotropic glutamate receptor mGluR7b binds to the catalytic gamma-subunit of protein phosphatase 1. J Neurochem 81:1130\u20131140","journal-title":"J Neurochem"},{"key":"5183_CR95","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0014-5793(02)02361-X","volume":"514","author":"R Enz","year":"2002","unstructured":"Enz R (2002) The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. FEBS Lett 514:184\u2013188","journal-title":"FEBS Lett"},{"key":"5183_CR96","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1471-4159.2006.04121.x","volume":"99","author":"F Bertaso","year":"2006","unstructured":"Bertaso F, Lill Y, Airas JM, Espeut J, Blahos J, Bockaert J, Fagni L, Betz H et al (2006) MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulates G protein-mediated constitutive inhibition of calcium channels. J Neurochem 99:288\u2013298","journal-title":"J Neurochem"},{"key":"5183_CR97","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/bj20020481","volume":"365","author":"O El Far","year":"2002","unstructured":"El Far O, Betz H (2002) G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes. Biochem J 365:329\u2013336","journal-title":"Biochem J"},{"key":"5183_CR98","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.neuron.2008.03.028","volume":"58","author":"YH Suh","year":"2008","unstructured":"Suh YH, Pelkey KA, Lavezzari G, Roche PA, Huganir RL, McBain CJ, Roche KW (2008) Corequirement of PICK1 binding and PKC phosphorylation for stable surface expression of the metabotropic glutamate receptor mGluR7. Neuron 58:736\u2013748","journal-title":"Neuron"},{"key":"5183_CR99","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nn.2142","volume":"11","author":"F Bertaso","year":"2008","unstructured":"Bertaso F, Zhang C, Scheschonka A, de Bock F, Fontanaud P, Marin P, Huganir RL, Betz H et al (2008) PICK1 uncoupling from mGluR7a causes absence-like seizures. Nat Neurosci 11:940\u2013948","journal-title":"Nat Neurosci"},{"key":"5183_CR100","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1523\/JNEUROSCI.20-19-07252.2000","volume":"20","author":"KK Dev","year":"2000","unstructured":"Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S (2000) PICK1 interacts with and regulates PKC phosphorylation of mGLUR7. J Neurosci 20:7252\u20137257","journal-title":"J Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05183-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05183-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05183-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:08:50Z","timestamp":1759997330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05183-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5183"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05183-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal studies were approved by the Vanderbilt University Medical Center IACUC Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}